Martek Biosciences Corporation Sustainability Profile
Martek Biosciences Corporation, a leading innovator in the biotechnology sector, is headquartered in the United States. Founded in 1985, the company has established itself as a key player in the development of nutritional products, particularly in the areas of omega-3 fatty acids and other essential nutrients. With a strong focus on health and wellness, Martek's core offerings include algal oils and DHA-rich products, which are renowned for their sustainability and health benefits. Over the years, Martek has achieved significant milestones, including partnerships with major food and beverage companies, solidifying its position in the global market. The company is recognised for its commitment to research and development, ensuring that its products meet the highest standards of quality and efficacy. As a pioneer in the industry, Martek Biosciences continues to lead the way in providing innovative solutions that support healthy living.
DitchCarbon Score
How does Martek Biosciences Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Martek Biosciences Corporation's score of 85 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Martek Biosciences Corporation, headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of DSM-Firmenich AG, which influences its climate commitments and initiatives. While no absolute emissions figures are provided, Martek Biosciences Corporation is aligned with the sustainability goals set by its parent company, DSM-Firmenich AG. This includes participation in various climate initiatives such as the Science Based Targets initiative (SBTi) and the CDP (formerly Carbon Disclosure Project), which guide their emissions reduction strategies. As part of its commitment to sustainability, Martek is expected to adhere to the reduction targets and climate pledges established by DSM-Firmenich AG, although specific targets for Martek itself have not been disclosed. The company is also involved in initiatives like RE100 and the Race to Zero campaign, which further emphasise its dedication to reducing carbon emissions and promoting climate action. In summary, while specific emissions data for Martek Biosciences Corporation is not available, its climate commitments are shaped by its relationship with DSM-Firmenich AG, reflecting a broader corporate responsibility towards sustainability and emissions reduction.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 1,030,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 590,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 8,683,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - | 00,000,000,000 | 0,000,000,000 | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is Martek Biosciences Corporation's Industry?
How Carbon Intensive is Martek Biosciences Corporation's Location?
Martek Biosciences Corporation's Scope 3 Categories Breakdown
Martek Biosciences Corporation's Scope 3 emissions, which increased by 7% last year and increased by approximately 28% since 2016, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 75% of Scope 3 emissions.
Top Scope 3 Categories
Martek Biosciences Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Martek Biosciences Corporation has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
